Determination of tissue-blood partition coefficients for a physiological model for humans, and estimation of dioxin concentration in tissues

Chemosphere

Volumn 46, Issue 7, 2002, Pages 975-985

  Maruyama, Wakae ^a,b   Yoshida, Kikuo ^a,c   Tanaka, Takayuki ^a   Nakanishi, Junko ^a,c  

^a YOKOHAMA NATIONAL UNIVERSITY   (Japan)

^b Japan Food Hygiene Association   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Dioxin; Human tissue; PBPK model; PCDD; PCDF

Indexed keywords

BLOOD; MUSCLE; PHARMACOKINETICS; PHYSIOLOGICAL MODELS; SKIN;

PARTITION COEFFICIENTS;

TISSUE;

DIOXIN; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN;

DIOXIN;

ADIPOSE TISSUE; ARTICLE; AUTOPSY; BILE; CONTROLLED STUDY; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD INTAKE; HUMAN; HUMAN TISSUE; JAPAN; KIDNEY; LIVER; MALE; MONTE CARLO METHOD; MUSCLE; PARTITION COEFFICIENT; SKIN;

EID: 0036171060     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-6535(01)00208-9     Document Type: Article

References (43)

1. Quantitative relations in the physiological constitutions of mammals
2. A multicompartment geometric model of liver in relation to regional induction of cytochrome P450s
3. Modeling receptor-mediated processes with dioxins: Implications for pharmacokinetics and risk assessment
4. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. I. Nonlinear distribution of PCDD/PCDF body burden between liver and adipose tissues
5. Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/PCDFs
6. Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): Assessing the impact of specific model parameters on sequestration in liver and fat in the rat
7. Reproductive toxicity and tissue concentrations of low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male off-spring rats exposed throughout pregnancy and lactation
8. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin
9. Alterations in the developing immune system of the F334 rat after perinatal exposure to 2,3,7,8-tetrachlo-rodibenzo-p-dioxin/II. Effects on the pup and adult
10. Partition constants of chlorinated dibenzofurans and dibenzo-p-dioxins
11. Concentrations and distribution of PCDDs, PCDFs and coplanar PCBs in various human tissues
12. Polychlorinated dibenzo-p-dioxins and related compounds: Correlations of levels in human tissues and in blood
13. Recent trend of polychlorinated dibenzo-p-dioxins and their related compounds in the blood and sebum of Yusho and Yu-Cheng patients
14. Dioxins and dibenzofurans in blood and adipose tissue of agent orange-exposed Vietnam veterans and matched controls
15. Assessing the elimination of 2,3,7,8-TCDD from humans with a physiologically based pharmacokinetic model
16. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats
17. A mechanistic model of effects of dioxin on gene expression in the rat liver
18. A pharmacokinetic analysis of interspecies extrapolation in dioxin risk assessment
19. A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice
20. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat
21. A physiologically based pharmacokinetic model for 2,3,7, 8-tetrachlorodibenzodioxin
22. Relative distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in hepatic and adipose tissues
23. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3 Effects on spermatogenesis and reproductive capability
24. Fugacity revisited. The fugacity approach to environmental transport
25. Evaluating the environmental behavior of chemicals with a level III fugacity model
26. Cancer mortality among workers in chemical plant contaminated with dioxin
27. Dioxin hepatic carcinogenesis: Biologically motivated modeling and risk assessment
28. A steady-state fugacity-based pharmacokinetic model with simultaneous multiple exposure routes
29. A physiologically based description of the inhaled pharmacokinetics of stylene in rats and humans
30. Variation of dioxins and furans in human tissues
31. Tissue distribution of dioxin and furans in humans from the general population
32. Partitioning of dioxins, dibenzofurans, and coplanar PCBs in blood, milk, adipose tissue, placenta and blood from five American women
33. Partitioning of 2,3,7,8-chlorinated dibenzo-p-dioxins and dibenzofurans between adipose tissue and plasma lipid of 20 Massachusetts Vietnam veterans
34. Dioxin in food
35. Comparison of the polychlorinated dibenzo-p-dioxin and dibenzofuran in human tissue and human liver
36. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife
37. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats
38. Thirty-four-year mortality follow-up of BASF employees exposed to 2,3,7,8-TCDD after the 1953 accident